INSILICO Aktie

>INSILICO Aktienkurs

6.4 EUR -5.2% (TradegateBSX)

Ask: 6.4 EUR / 779 Stück

Bid: 6.2 EUR / 808 Stück

Tagesumsatz: 348 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

INSILICO Aktie über LYNX handeln

Intraday

1 Jahr

>INSILICO Performance

1 Woche: -0,8%

1 Monat: +5,8%

3 Monate: 0%

6 Monate: 0%

1 Jahr: 0%

laufendes Jahr: 0%

>INSILICO Aktie

Name:

INSILICO MEDICINE

Land:

China

Sektor:

Gesundheit

ISIN/ Wkn:

KYG4790P1037 / A41XT7

Symbol/ Ticker:

O15 (Frankfurt)

Kürzel:

FRA:O15, ETR:O15, O15:GR

Index:

Webseite:

https://insilico.com/

Profil:

InSilico Medicine Cayman TopCo is a biotechnology company applying artificial intelligence and automation technologies to drug discovery and development. The company operates the Pharma.AI platform, an AI-enabled suite that accelerates the entire dru..
>Volltext..

Marktkapitalisierung:

3845.57 Mio. EUR

Unternehmenswert:

Umsatz:

EBITDA:

Nettogewinn:

Gewinn je Aktie:

Schulden:

Liquide Mittel:

Operativer Cashflow:

Bargeldquote:

Umsatzwachstum:

Gewinnwachstum:

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

INSILICO

Letzte Datenerhebung:

05.04.26

>INSILICO Kennzahlen

Aktien/ Unternehmen:

Aktien: 572.4 Mio. St.

Frei handelbar: 78.41%

Leerverk. Aktien: -

Rückkaufquote: -

Mitarbeiter: -

Umsatz/Mitarb.: -

Analysten:

Analystenrating: Strong buy

Kursziel: 35.5%

Bewertung:

KGV: -

KGV lG: 292.09

KUV: -

KBV: -

PEG-Ratio: -

EV/EBITDA: -

Rentabilität:

Bruttomarge: -

Gewinnmarge: -

Operative Marge: -

Managementeffizenz:

Gesamtkaprendite: -

Eigenkaprendite: -

>INSILICO Peer Group

Gesundheit, Nahrungsergänzungsmittel & Wellnessprodukte, Onkologie/ Krebs- Behandlung

>INSILICO Chart & Kurs - Tradegate

>INSILICO News

31.03.26 - 03:48	Eli Lilly teams up with Insilico to accelerate AI-powered drug development (Proactive Investors)
	Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...

30.03.26 - 18:15	Healthcare ETFs in Spotlight Amid Eli Lily′s $2.8B AI Drug Move (Zacks)
	Eli Lilly's $2.75B AI drug deal with Insilico spotlights healthcare ETFs as investors seek diversified exposure to the fast-growing AI-driven pharma space....

30.03.26 - 08:48	Neuer Milliarden-Deal: Eli Lilly greift nach der nächsten Pharma-Revolution (Wallstreet-Online)
	Eli Lilly investiert Milliarden in künstliche Intelligenz, um die nächste Generation von Medikamenten zu entwickeln. Die Kooperation mit Insilico könnte Forschung radikal beschleunigen – und den Wettbewerb neu ordnen....

30.03.26 - 08:21	Eli Lilly baut KI-Offensive aus: Verstärkt der Insilico-Deal den Druck auf die Novo Nordisk-Aktie? (Finanzen.net)
	Eli Lilly baut seine KI-Strategie massiv aus. Ein milliardenschwerer Deal zeigt, wie stark künstliche Intelligenz die Arzneimittelentwicklung verändern könnte....

30.03.26 - 08:01	Eli Lilly: Milliardenschwerer KI-Deal – die Details (Der Aktionaer)
	Der Pharma-Riese Eli Lilly baut seine KI-gestützte Wirkstoffforschung aus. Wie am Wochenende bereits zuvor die Financial Times (FT) berichtete, schnüren die Amerikaner einen milliardenschweren Deal mit der in Hongkong gelisteten Insilico Medicine....

30.03.26 - 07:24	Eli Lilly schließt Wirkstoff-Forschungsdeal mit InSilico im Wert von bis zu 2,75 Mrd. US-Dollar (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

30.03.26 - 04:18	Eli Lilly, InSilico Strike AI Drug Discovery Deal (WSJ EN)
	Hong Kong-listed InSilico sad the deal could be valued at as much as $2.75 billion....

30.03.26 - 03:30

Hong Kong-listed Insilico Medicine signs AI drug development deal with Eli Lilly (SCMP)

Insilico Medicine has signed a potential multibillion-dollar deal with Eli Lilly to license out an early-stage drug pipeline and provide its artificial intelligence platform services in research and development collaborations. Under the agreement announced on Monday, US-headquartered, Hong Kong-listed Insilico will receive an upfront payment of US$115 million. The deal could have a total value of around US$2.75 billion tied to development, regulatory and commercial milestones, plus tiered......

30.03.26 - 03:15	Results: Insilico Medicine Annual Loss Widens Sharply to USD352 Million (AAStocks)
	Insilico Medicine (03696.HK), focusing on AI-enabled drug development, announced its 2025 results. The annual total revenue was USD56.239 million, representing a year-on-year decrease of approximately 34.5%. The company recorded a loss of USD352.3 million, compared to a loss of USD17.096 million in 2024, marking a 19.6-fold incr......

30.03.26 - 03:15	Insilico Medicine Reaches Global Pipeline Licensing and AI Drug Development Collaboration with Eli Lilly (AAStocks)
	Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...

30.03.26 - 02:33	Insilico Medicine Announces Global R&D Collaboration with Lilly (PR Newswire)
	AI-driven collaboration includes an exclusive worldwide license for a portfolio of programs spanning multiple therapeutic areas. CAMBRIDGE, Mass., March 29, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", HKEX: 3696), a clinical-stage biotechnology company powered by generative......

29.03.26 - 22:18	Eli Lilly Secures $2.75 Billion Deal With Insilico Medicine To Bring AI-Developed Drugs To Global Market: Report (Benzinga)
	Eli Lilly's deal involves an upfront payment of $115 million to Insilico, with additional payments tied to milestones. Importance Rank: 1 read more...

29.03.26 - 18:00	Insilico Medicine Strikes $2.75 Bln AI Drug Discovery Deal With Eli Lilly (AFX)
	INDIANAPOLIS (dpa-AFX) - InSilico Medicine Cayman TopCo (3696.HK) announced that it has entered into a licensing and drug discovery collaboration with Eli Lilly and Company (LLY). The partnership ......

29.03.26 - 15:54	Eli Lilly expands AI drug push with multibillion-dollar Insilico deal (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

29.03.26 - 15:42	Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market (CNBC)
	U.S. pharmaceutical giant Eli Lilly will give Hong Kong-listed Insilico $115 million upfront to bring some of its AI-discovered drugs to the global market....

29.03.26 - 15:15	Results: Insilico Medicine Expands Annual Loss to USD352 Million (AAStocks)
	Insilico Medicine (03696.HK) announced its financial results for the fiscal year 2025, reporting revenue of USD56.24 million, a year-on-year decrease of 34.5%. The loss expanded from USD17.1 million in the previous year to USD352 million, with a loss per share of USD4.48. No final dividend was declared. (de/d)~AASTOCKS Financial......

29.03.26 - 14:57	InSilico, Lilly ink AI drug discovery deal worth up to $2.75 billion (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

29.03.26 - 14:36	Lilly, Insilico Ink Deal on AI Drugs Worth Up to $2.75 Billion (Bloomberg)
	Eli Lilly & Co. has signed an AI-powered drug development deal with Insilico Medicine that could be worth up to $2.75 billion....

26.03.26 - 15:09	Insilico Medicine and Tenacia Biotechnology Expand AI-Driven CNS Collaboration with Deal Value Up to US$94.75 Million (PR Newswire)
	CAMBRIDGE, Mass., March 26, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, and Tenacia Biotechnology (Hong Kong) Co., Limited ("Tenacia"), a commercial-stage biopharmaceutical company......

26.03.26 - 02:30	Insilico Medicine and Yuanqi Bio Expand AI-Driven R&D Collaboration Involving Up to USD94.75 Million (AAStocks)
	Insilico Medicine (03696.HK) announced that it has reached an expanded AI-driven R&D collaboration with the commercial biopharmaceutical company Yuanqi Bio. Through this collaboration, the two parties aim to provide broader and more precise treatment solutions for highly challenging neurological diseases, thereby reducing late-s......

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Notwendigkeit ist bei weitem stärker als die Kunst. - Aischylos

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram